ULURU Inc., a specialty medical technology company, researches, develops, and commercializes a range of wound care and muco-adhesive film products based on its patented Nanoflex and OraDisc technologies in the United States and internationally. The company provides Altrazeal, a transforming powder dressing that is used for the treatment of various wounds, such as partial thickness burns, donor sites, and surgical and traumatic wounds, as well as chronic wounds, including diabetic foot, venous leg, and pressure ulcers. Its products also include Aphthasol paste for the treatment of canker sores; OraDisc A for canker sores; and OraDisc B, which is used for the treatment and management of oral pain. ULURU Inc. and is headquartered in Addison, Texas.

Overall MarketRank^™

0.34 out of 5 stars

Medical Sector

1775th out of 2,042 stocks

Pharmaceutical Preparations Industry

708th out of 770 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for ULURU.

1.7 Community Rank

Outperform Votes
ULURU has received 41 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
ULURU has received 81 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
ULURU has received 66.39% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about ULURU and other stocks. Vote “Outperform” if you believe ULUR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ULUR will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
ULURU does not currently pay a dividend.
Dividend Growth
ULURU does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, ULURU insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.10% of the stock of ULURU is held by insiders.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

ULURU (OTCMKTS:ULUR) Frequently Asked Questions

What stocks does MarketBeat like better than ULURU?

Wall Street analysts have given ULURU a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but ULURU wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting ULURU?

ULURU saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 300 shares, a drop of 85.7% from the March 15th total of 2,100 shares. Based on an average trading volume of 5,800 shares, the short-interest ratio is presently 0.1 days.
View ULURU's Short Interest.

How has ULURU's stock price been impacted by Coronavirus?

ULURU's stock was trading at $0.0255 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, ULUR shares have increased by 1,002.0% and is now trading at $0.2810.
View which stocks have been most impacted by COVID-19.

Who are ULURU's key executives?

ULURU's management team includes the following people:

Ms. Vaidehi A. Shah, Chairman & CEO (Age 44, Pay $101.88k)
Mr. Anish Vithaldas Shah, VP & Director (Age 54)
Ms. Oksana V. Tiedt, VP of Clinical & International Affairs and Director (Age 45)
Mr. P. K Ramachandran, Chief Financial Officer (Age 67)

Who are some of ULURU's key competitors?

Some companies that are related to ULURU include Generex Biotechnology (GNBT), Amarillo Biosciences (AMAR), RegeneRx Biopharmaceuticals (RGRX), NovaBay Pharmaceuticals (NBY), Pharmaxis (PXSLY), Integrated BioPharma (INBP), Immuron (IMRN), Alterity Therapeutics (ATHE), China Pharma (CPHI), Artelo Biosciences (ARTL), Akari Therapeutics (AKTX), Sonnet BioTherapeutics (SONN), EyeGate Pharmaceuticals (EYEG), InMed Pharmaceuticals (INM) and PainReform (PRFX).
View all of ULUR's competitors.

What other stocks do shareholders of ULURU own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ULURU investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), (PCSA), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX), Entasis Therapeutics (ETTX), Evelo Biosciences (EVLO), (HGEN) and Jaguar Health (JAGX).

What is ULURU's stock symbol?

ULURU trades on the OTCMKTS under the ticker symbol "ULUR."

How do I buy shares of ULURU?

Shares of ULUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ULURU's stock price today?

One share of ULUR stock can currently be purchased for approximately $0.28.

How much money does ULURU make?

ULURU has a market capitalization of $8.17 million.

How many employees does ULURU have?

ULURU employs 2 workers across the globe.

What is ULURU's official website?

The official website for ULURU is www.uluruinc.com.

Where are ULURU's headquarters?

ULURU is headquartered at 4410 BELTWAY DRIVE, ADDISON TX, 75001.

How can I contact ULURU?

ULURU's mailing address is 4410 BELTWAY DRIVE, ADDISON TX, 75001. The specialty pharmaceutical company can be reached via phone at 214-905-5145.

This page was last updated on 5/9/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

ULURU Stock Forecast, Price & News

Adding

Adding

Adding ULURU Inc.

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Headlines

About ULURU

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

1.7 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.0 Dividend Strength

Dividend Yield

Dividend Growth